Ted Meadows, lead pain pump attorney, discusses the issues surrounding the use of intra-articular post-operative pain pumps.  Pain pumps that dispense medicine directly to the join space can cause permanent cartilage damage, which can lead to joint replacement surgery, shoulder fusion, and amputation in extreme circumstances.

Trasylol, manufactered by Bayer Pharmaceuticals, has been used for more than twenty years to help reduce bleeding during surgery. Trasylol was permanently recalled in May 2008. Estimates are that over 1,000 people died each month from the use of Trasylol.

Vytorin is a prescription drug marketed by Merck and Shering-Plough for treating high cholesterol.  Vytorin has recently come under incredible scrutiny as new information shows that the drug is ineffective, incredibly expensive and may actually cause cancer.

Chad Cook explain the dangers of the blood thinner Heparin. Widely used as an injectable anticoagulant and it derived from pig intestines, Heparin recently came under scrutiny after tainted heparin stock imported from china led to six major recalls of the medicine. The FDA reported 785 serious injuries and 395 death linked to Heparin.

Chad Cook, lead Digitek attorney, speaks about the recent Digitek recall. Digitek was recalled in April 2008 after medicine was found to contain twice the active ingredient - digitalis. Digitek overdose can lead to bradycardia, extremely low blood pressure, and even death. Digitek is often given to patients in the hospital during a heart procedure.

Chad Cook, lead Fosamax attorney, discusses ongoing Fosamax litigation. Recent studies demonstrate a clear link between osteonecrosis and Fosamax. The irony is that these drugs, such as Fosamax, that are prescribed to prevent bone decay may actually be causing bone decay - such as osteonecrosis of the jaw (ONJ).

The FDA recently released a public health advisory warning people of the dangers of Chantix. The FDA had more accounts of serious side effects caused by Chantix than all other drugs combined. Including psychosis, psychotic disorders, suicide, vision disturbances and diabetes.

In September, the FDA began posting on its web site a list of drugs it is investigating for adverse side effects. The new program is required by Congress, in response to public demand for more transparency in the drug investigation process. Here, Legal Briefs' Amy Yeargan talks about the program.

Families of patients killed by the tainted blood thinner Heparin testified before Congress yesterday. An FDA official said the agency needs more resources to improve drug manufacturing inspections